- Home
- KOSS vs GUTS Comparison
KOSS vs GUTS Comparison
Compare KOSS & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- GUTS
- Stock Information
- Founded
- KOSS 1953
- GUTS 2010
- Country
- KOSS United States
- GUTS United States
- Employees
- KOSS N/A
- GUTS N/A
- Industry
- KOSS Consumer Electronics/Appliances
- GUTS
- Sector
- KOSS Consumer Staples
- GUTS
- Exchange
- KOSS Nasdaq
- GUTS NYSE
- Market Cap
- KOSS 59.3M
- GUTS 58.8M
- IPO Year
- KOSS N/A
- GUTS 2024
- Fundamental
- Price
- KOSS $5.32
- GUTS $1.52
- Analyst Decision
- KOSS
- GUTS Buy
- Analyst Count
- KOSS 0
- GUTS 1
- Target Price
- KOSS N/A
- GUTS $10.00
- AVG Volume (30 Days)
- KOSS 82.2K
- GUTS 785.4K
- Earning Date
- KOSS 08-28-2025
- GUTS 08-13-2025
- Dividend Yield
- KOSS N/A
- GUTS N/A
- EPS Growth
- KOSS N/A
- GUTS N/A
- EPS
- KOSS N/A
- GUTS N/A
- Revenue
- KOSS $12,433,361.00
- GUTS $60,000.00
- Revenue This Year
- KOSS N/A
- GUTS N/A
- Revenue Next Year
- KOSS N/A
- GUTS N/A
- P/E Ratio
- KOSS N/A
- GUTS N/A
- Revenue Growth
- KOSS N/A
- GUTS N/A
- 52 Week Low
- KOSS $4.00
- GUTS $0.87
- 52 Week High
- KOSS $11.84
- GUTS $4.92
- Technical
- Relative Strength Index (RSI)
- KOSS 56.94
- GUTS 41.63
- Support Level
- KOSS $5.14
- GUTS $1.47
- Resistance Level
- KOSS $5.37
- GUTS $1.68
- Average True Range (ATR)
- KOSS 0.28
- GUTS 0.14
- MACD
- KOSS 0.05
- GUTS -0.03
- Stochastic Oscillator
- KOSS 71.58
- GUTS 9.80
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.